Great posts and I appreciate the time you take as well as the insider knowledge on corporate governance. Last year there was a gap in options from 1/2021-5/2021 and the share price was hovering around 4x more than what it was for the current tranche at .59 with 200k per director able to be exercised retroactively from 6/1 execution to 5/21 exercisable. This current 400k per director is less value and limited to a year holding or more.